HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Amir-Reza Hosseinpour Victor T. Tsang Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hosseinpour, A.-R. Articles by Tsang, V. T. Search for Related Content PubMed PubMed Citation Articles by Hosseinpour, A.-R. Articles by Tsang, V. T. Related Collections Congenital - acyanotic Congenital - cyanotic Transplantation - heart

Eur J Cardiothorac Surg 2006;30:508-514
© 2006 Elsevier Science NL

Review

Transplantation for adults with congenital heart disease

^a Birmingham Children's Hospital, Steelhouse Lane, Birmingham B4 6NH, UK
^b UCLH Hospital and Great Ormond Street Hospital for Children, London, UK

Received 2 March 2006; received in revised form 31 May 2006; accepted 2 June 2006.

^_* Corresponding author. Tel.: +44 20 78138159; fax: +44 20 74301281. (Email: tsangv{at}gosh.nhs.uk).

Heart transplantation is a recognised treatment for end-stage heart failure of any cause including congenital heart disease. Congenital heart disease has contributed relatively little to the adult heart transplant activities in the past two decades. However, this is likely to change as an increasing number of children with congenital heart disease reach adulthood because of the advances in paediatric cardiology and surgery. Some of these grown-ups with congenital heart disease (GUCH patients) will need transplantation for late myocardial dysfunction either secondary to uncorrected lesions, or despite previous repair or palliative surgery. These patients are managed along the same clinical principles as those with cardiac failure of other aetiologies, despite the lack of any evidence to support this approach. Nevertheless, they introduce new challenges. First, some may have pulmonary vascular disease and require heart–lung transplantation, or lung transplantation combined with repair of their cardiac defects. Second, those with failing Fontan circulation are usually much sicker than other transplant candidates, with protein-losing enteropathy along with renal and hepatic dysfunction. Third, a suitable donor organ may not be found due to elevated levels of antibodies in response to previous blood transfusions and possibly the previous implantation of homografts. Fourth, the operation may be technically difficult because of the presence of adhesions secondary to previous operations, collaterals, and unusual anatomy. Fifth, postoperative care may be complicated because of predisposition to bleeding, infection and pulmonary hypertension, and the presence of residual aortopulmonary collaterals resulting in a significant left-to-right shunt. Despite a higher early mortality, the overall results of heart transplantation so far have been encouraging with survivals similar to that of adults with acquired heart disease and that of the paediatric population. However, this may change as the proportion of high-risk patients (failing Fontans) increases. GUCH patients with Eisenmenger's syndrome may be offered lung transplantation with repair of the cardiac defect or heart–lung transplantation. However, because of the limited success of these approaches, and improved management of pulmonary hypertension, patient selection remains difficult.

Key Words: Congenital heart disease • GUCH • Transplantation

This article has been cited by other articles:

				D. T. Hsu and G. D. Pearson Heart Failure in Children: Part I: History, Etiology, and Pathophysiology Circ Heart Fail, January 1, 2009; 2(1): 63 - 70. [Full Text] [PDF]

				S. A. Hunt and F. Haddad The Changing Face of Heart Transplantation J. Am. Coll. Cardiol., August 19, 2008; 52(8): 587 - 598. [Abstract] [Full Text] [PDF]

				J. Simmonds, M. Burch, H. Dawkins, and V. Tsang Heart transplantation after congenital heart surgery: improving results and future goals. Eur. J. Cardiothorac. Surg., August 1, 2008; 34(2): 313 - 317. [Abstract] [Full Text] [PDF]

				J. Horer, E. Karl, G. Theodoratou, C. Schreiber, J. Cleuziou, Z. Prodan, M. Vogt, and R. Lange Incidence and results of reoperations following the Senning operation: 27 years of follow-up in 314 patients at a single center Eur. J. Cardiothorac. Surg., June 1, 2008; 33(6): 1061 - 1067. [Abstract] [Full Text] [PDF]

				H. Goerler, A. Simon, B. Gohrbandt, C. Hagl, P. Oppelt, J. Weidemann, A. Haverich, and M. Strueber Heart lung and lung transplantation in grown-up congenital heart disease: long-term single centre experience Eur. J. Cardiothorac. Surg., December 1, 2007; 32(6): 926 - 931. [Abstract] [Full Text] [PDF]

				K. Kallenbach, A. R. Simon, A. Haverich, and M. Struber Heart lung transplantation in a patient with large aortopulmonary collaterals by means of an extended approach J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 543 - 544. [Full Text] [PDF]